| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |